BOSON Trademark

Trademark Overview

On Friday, November 19, 2021, a trademark application was filed for BOSON with the United States Patent and Trademark Office. The USPTO has given the BOSON trademark a serial number of 97134074. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 18, 2024. This trademark is owned by Xiamen Boson Biotech Co. Ltd.. The BOSON trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic test kits comprised of nasal swabs and medical diagnostic assay test strips embedded in a card to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases; Medical analytic test kits comprised of nasal swabs and medical diagnostic assay test strips embedded in a card to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases; In vitro medical diagnostic test kits comprised of nasal swabs and medical diagnostic assay test strips embedded in a card to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases
boson

General Information

Serial Number97134074
Word MarkBOSON
Filing DateFriday, November 19, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Goods and ServicesMedical diagnostic test kits comprised of nasal swabs and medical diagnostic assay test strips embedded in a card to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases; Medical analytic test kits comprised of nasal swabs and medical diagnostic assay test strips embedded in a card to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases; In vitro medical diagnostic test kits comprised of nasal swabs and medical diagnostic assay test strips embedded in a card to detect cardiac markers, drugs of abuse, fertility hormones, infectious diseases, tumor markers and animal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXiamen Boson Biotech Co. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressXiamen 361021
CN
Party NameXiamen Boson Biotech Co. Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressXiamen 361021
CN

Trademark Events

Event DateEvent Description
Tuesday, November 23, 2021NEW APPLICATION ENTERED
Wednesday, November 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 31, 2022ASSIGNED TO EXAMINER
Thursday, September 1, 2022NON-FINAL ACTION WRITTEN
Thursday, September 1, 2022NON-FINAL ACTION E-MAILED
Thursday, September 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 4, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 24, 2022FINAL REFUSAL WRITTEN
Monday, October 24, 2022FINAL REFUSAL E-MAILED
Monday, October 24, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 7, 2022NON-FINAL ACTION WRITTEN
Monday, November 7, 2022NON-FINAL ACTION E-MAILED
Monday, November 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 3, 2023ASSIGNED TO LIE
Monday, July 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2023NON-FINAL ACTION WRITTEN
Monday, October 2, 2023NON-FINAL ACTION E-MAILED
Monday, October 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, February 5, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, March 10, 2024NON-FINAL ACTION WRITTEN
Sunday, March 10, 2024NON-FINAL ACTION E-MAILED
Sunday, March 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION

Related Keywords

boson medical markers diseases test diagnostic abuse fertility drugs hormones tumor